NCT05700448 2026-02-05Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell LymphomaCStone PharmaceuticalsPhase 3 Not yet recruiting150 enrolled
NCT04509466 2024-03-07Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1/2 Terminated41 enrolled